Owing to its abundance and essential physiological function, a pharmacological chaperone and modulator of rod opsin could slow the visual cycle for treatment of retinal degenerations related to all-trans-retinal toxicity, such as Stargardt disease27–29, and adRP resulting from rhodopsin folding defects30. The gene discussed is RHO; the disease is retinal degeneration.